Literature DB >> 28834343

Corrigendum.

.   

Abstract

Year:  2017        PMID： 28834343      PMCID： PMC6885953          DOI： 10.1111/dom.13074

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN： 1462-8902            Impact factor:   6.577


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of autoinjected exenatide once-weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: The DURATION-NEO-2 randomized clinical study.

Authors:  Kishore M Gadde; Marion L Vetter; Nayyar Iqbal; Elise Hardy; Peter Öhman
Journal:  Diabetes Obes Metab       Date:  2017-03-17       Impact factor: 6.577
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.